GB2308545A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB2308545A
GB2308545A GB9707483A GB9707483A GB2308545A GB 2308545 A GB2308545 A GB 2308545A GB 9707483 A GB9707483 A GB 9707483A GB 9707483 A GB9707483 A GB 9707483A GB 2308545 A GB2308545 A GB 2308545A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9707483A
Other versions
GB2308545B (en
GB9707483D0 (en
Inventor
Sylvain Cottens
Barbara Haeberlin
Richard Sedrani
Jacky Vonderscher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421613A external-priority patent/GB9421613D0/en
Priority claimed from GB9422084A external-priority patent/GB9422084D0/en
Priority claimed from GBGB9425353.1A external-priority patent/GB9425353D0/en
Priority claimed from GBGB9517133.6A external-priority patent/GB9517133D0/en
Priority to GB9707483A priority Critical patent/GB2308545B/en
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Priority to GB9818245A priority patent/GB2327611B/en
Priority claimed from PCT/EP1995/004187 external-priority patent/WO1996013273A1/en
Publication of GB9707483D0 publication Critical patent/GB9707483D0/en
Publication of GB2308545A publication Critical patent/GB2308545A/en
Publication of GB2308545B publication Critical patent/GB2308545B/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
GB9707483A 1994-10-26 1995-10-25 Pharmaceutical microemulsion preconcentrates Expired - Lifetime GB2308545B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9818245A GB2327611B (en) 1994-10-26 1995-10-25 Macrolide compositions
GB9707483A GB2308545B (en) 1994-10-26 1995-10-25 Pharmaceutical microemulsion preconcentrates

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9421613A GB9421613D0 (en) 1994-10-26 1994-10-26 Organic compounds
GB9422084A GB9422084D0 (en) 1994-11-02 1994-11-02 Organic compounds
GBGB9425353.1A GB9425353D0 (en) 1994-12-15 1994-12-15 Organic compounds
GBGB9517133.6A GB9517133D0 (en) 1995-08-22 1995-08-22 Pharmaceutical compositions
PCT/EP1995/004187 WO1996013273A1 (en) 1994-10-26 1995-10-25 Pharmaceutical compositions
GB9707483A GB2308545B (en) 1994-10-26 1995-10-25 Pharmaceutical microemulsion preconcentrates

Publications (3)

Publication Number Publication Date
GB9707483D0 GB9707483D0 (en) 1997-05-28
GB2308545A true GB2308545A (en) 1997-07-02
GB2308545B GB2308545B (en) 1999-06-02

Family

ID=27517264

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9707483A Expired - Lifetime GB2308545B (en) 1994-10-26 1995-10-25 Pharmaceutical microemulsion preconcentrates

Country Status (1)

Country Link
GB (1) GB2308545B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949257B2 (en) 1998-05-26 2005-09-27 Novartis Ag Pharmaceutical compositions
US8575147B2 (en) 1999-02-16 2013-11-05 Novartis Ag Spontaneously dispersible N-benzoyl staurosporine compositions

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636534A1 (en) * 1988-09-16 1990-03-23 Sandoz Sa PHARMACEUTICAL COMPOSITIONS BASED ON CYCLOSPORINS
FR2678169A1 (en) * 1991-06-27 1992-12-31 Sandoz Sa NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLOSPORINE FOR ORAL ADMINISTRATION.
WO1994005312A1 (en) * 1992-09-07 1994-03-17 Galena, A.S. Medical preparations containing n-methylated cyclic undecapeptides
EP0589843A1 (en) * 1992-09-25 1994-03-30 Sandoz Ag Pharmaceutical compositions containing cyclosporins
DE4418115A1 (en) * 1993-05-27 1994-12-01 Sandoz Ag Pharmaceutical preparations contg macrolide antibiotics
GB2282586A (en) * 1993-09-28 1995-04-12 Scherer Gmbh R P Soft gelatin capsule manufacture

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636534A1 (en) * 1988-09-16 1990-03-23 Sandoz Sa PHARMACEUTICAL COMPOSITIONS BASED ON CYCLOSPORINS
FR2678169A1 (en) * 1991-06-27 1992-12-31 Sandoz Sa NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLOSPORINE FOR ORAL ADMINISTRATION.
WO1994005312A1 (en) * 1992-09-07 1994-03-17 Galena, A.S. Medical preparations containing n-methylated cyclic undecapeptides
EP0589843A1 (en) * 1992-09-25 1994-03-30 Sandoz Ag Pharmaceutical compositions containing cyclosporins
DE4418115A1 (en) * 1993-05-27 1994-12-01 Sandoz Ag Pharmaceutical preparations contg macrolide antibiotics
GB2282586A (en) * 1993-09-28 1995-04-12 Scherer Gmbh R P Soft gelatin capsule manufacture

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949257B2 (en) 1998-05-26 2005-09-27 Novartis Ag Pharmaceutical compositions
US8575147B2 (en) 1999-02-16 2013-11-05 Novartis Ag Spontaneously dispersible N-benzoyl staurosporine compositions
US8722664B2 (en) 1999-02-16 2014-05-13 Novartis Ag Spontaneously dispersible N-benzoyl staurosporine compositions

Also Published As

Publication number Publication date
GB2308545B (en) 1999-06-02
GB9707483D0 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
GB9417524D0 (en) Pharmaceutical compositions
HU9503199D0 (en) Pharmaceutical basic compositions
EG24118A (en) Pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
ZA954469B (en) Pharmaceutical compositions
GB9622681D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
GB2308545A (en) Pharmaceutical compositions
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
GB9413072D0 (en) Pharmaceutical compositions
GB9413423D0 (en) Pharmaceutical compositions
GB9401872D0 (en) Pharmaceutical compositions
GB9404457D0 (en) Pharmaceutical compositions
GB9407235D0 (en) Pharmaceutical compositions